Immix Biopharma Terminates Richard Graydon in 2026 with No Material Business Impact
Immix Biopharma, Inc. Files Form 8-K – No New Price-Sensitiv...
Sign in to continue:
Immix Biopharma, Inc. Files Form 8-K – No New Price-Sensitiv...
Data443 Risk Mitigation, Inc. Signs Financial Services Agree...
Rockwell Medical Regains Compliance with Nasdaq Listing Requ...
Bath & Body Works Announces Partial Redemption of Senior Not...
News Corp Announces \$1 Billion Stock Buyback Program Ne...
Brookfield and CPP Investments to Acquire LXP Industrial Tru...
AMC Entertainment Holdings Reports Record-Breaking Q2 2026 F...
Knightscope Q2 2026 Revenue Soars: Key Details for Investors...
LCI Industries Appoints Robert Hureau to Board of Directors:...
Magnolia Oil & Gas Announces Transformative \$4.06 Billion A...